Search results for "Renal Dialysi"

showing 10 items of 118 documents

Late, giant brachial artery aneurysm following hemodialysis fistula ligation in a renal transplant patient: case report and literature review.

2012

Brachial artery aneurysm (BAA) following long-standing arteriovenous fistula ligation after renal transplantation is uncommon. Herein, we describe the case of a 64-year-old man who developed a giant symptomatic BAA 21 years after ligation of the fistula. He was submitted to surgical excision of the aneurysm followed by interposition prosthetic graft.

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyBrachial ArteryFistulamedicine.medical_treatmentArteriovenous fistulaSettore MED/22 - Chirurgia VascolareArteriovenous Shunt SurgicalAneurysmRenal Dialysismedicine.arterymedicineHumanscardiovascular diseasesBrachial arteryLigationbusiness.industryBrachial artery aneurysm Renal transplantation Dialysis Surgical bypassGeneral MedicineMiddle Agedmedicine.diseaseAneurysmKidney TransplantationSurgeryTransplantationCardiothoracic surgerycardiovascular systemSurgeryRadiologyHemodialysisCardiology and Cardiovascular MedicineLigationbusiness
researchProduct

Impact of Sarcopenia on Clinical Outcomes of Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Cohort Study

2021

International audience; Background: The impact of sarcopenia in patients undergoing simultaneous liver and kidney transplantation (SLKT) has not been fully delineated. The aim of this single-centre-cohort-study was to evaluate the impact of sarcopenia on the clinical outcomes. Methods: Between 2003 and 2018, 79 patients underwent SLKT. Sarcopenia was assessed via the total psoas muscle area (TPA) at the level of the 3rd. lumbar vertebra. Sarcopenia threshold was TPA < 1460 mm2 (women) and <1560 mm2 (men). We identified post-operative biliary, vascular and digestive complications. Survival analysis was performed by the Kaplan Meier method (log-rank test). Results: We included 43/79 SLK…

MaleSarcopeniamedicine.medical_specialtymedicine.medical_treatment[SDV]Life Sciences [q-bio]Liver transplantationCohort Studies03 medical and health sciences0302 clinical medicineRenal DialysisInternal medicinemedicineHumansKidney transplantationDialysisHepatologybusiness.industryGastroenterologyPostoperative complicationMiddle Agedmedicine.diseaseKidney TransplantationLiver TransplantationTransplantationTreatment Outcome030220 oncology & carcinogenesisSarcopeniaCohortFemale030211 gastroenterology & hepatologybusinessCohort study
researchProduct

Determinants of enhanced thromboxane biosynthesis in renal transplantation

2001

Determinants of enhanced thromboxane biosynthesis in renal transplantation.BackgroundDespite great improvement in patient and graft survival, the long-term morbidity and mortality in renal transplant recipients (RTRs) are still significant, with a high incidence of cardiovascular disease-related deaths.MethodsWe investigated thromboxane (TXA2) biosynthesis and endothelial and coagulative activation in 65 patients who received a renal transplant.ResultsThe rate of TXA2 biosynthesis (urinary 11-dehydro-TXB2 excretion largely reflects platelet TXA2 production in vivo) was significantly (P < 0.0001) higher in RTRs than in healthy subjects. Plasma von Willebrand factor (vWF) and thrombin-antithr…

MaleSettore MED/09 - Medicina InternaThromboxanegraft survivalThromboxanevon Willebrand factorImmunosuppressive AgentThromboxane A2chemistry.chemical_compoundReference ValuesRenal Dialysicardiovascular diseaseReference ValuePlateletPostoperative PeriodKidney transplantationKidneyimmunosuppressionnephrotoxicityThromboxanesMiddle AgedCholesterolmedicine.anatomical_structureNephrologyCyclosporineFemaleCardiovascular disease; Graft survival; Immunosuppression; Kidney transplantation; Nephrotoxicity; Von Willebrand factor; Adult; Antithrombin III; Cardiovascular Diseases; Cholesterol; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Peptide Hydrolases; Postoperative Period; Reference Values; Renal Dialysis; Thromboxanes; von Willebrand Factor; Kidney Transplantation; NephrologyImmunosuppressive AgentsHumancirculatory and respiratory physiologyAdultmedicine.medical_specialtyAntithrombin IIIUrologykidney transplantationFollow-Up StudieEndothelial activationRenal DialysismedicineHumansPlatelet activationcardiovascular disease; cardiovascular diseases; graft survival; immunosuppression; kidney transplantation; nephrotoxicity; von willebrand factorbusiness.industrymedicine.diseasecardiovascular diseasesTransplantationPeptide HydrolasechemistryImmunologybusinessFollow-Up StudiesPeptide HydrolasesKidney International
researchProduct

Fenestrated Stent Grafting for Short-necked and Juxtarenal Abdominal Aortic Aneurysm

2010

Objectives: To present an 8-year clinical experience in the endovascular treatment of short-necked and juxtarenal abdominal aortic aneurysm (AAA) with fenestrated stent grafts. Methods: At our tertiary referral centre, all patients treated with fenestrated and branched stent grafts have been enrolled in an investigational device protocol database. Patients with short-necked or juxtarenal AAA managed with fenestrated endovascular aneurysm repair (F-EVAR) between November 2001 and April 2009 were retrospectively reviewed. Patients treated at other hospitals under the supervision of the main author were excluded from the study. Patients treated for suprarenal or thoraco-abdominal aneurysms wer…

MaleTime Factorsmedicine.medical_treatmentShort neckFenestrated graftKaplan-Meier EstimateOPEN REPAIREndovascular aneurysm repairSettore MED/22 - Chirurgia VascolareAortic aneurysmEVARNetherlandsAged 80 and overMedicine(all)medicine.diagnostic_testENDOGRAFT REPAIRMiddle AgedJuxtarenalAbdominal aortic aneurysmProsthesis FailureTreatment OutcomeFemaleKidney DiseasesStentsCardiology and Cardiovascular MedicineReoperationmedicine.medical_specialtyAortographyArterial Occlusive DiseasesFenestrated graftsProsthesis DesignAortographyRisk AssessmentBlood Vessel Prosthesis ImplantationAneurysmRenal DialysisBlood vessel prosthesismedicineHumanscardiovascular diseasesAgedRetrospective Studiesbusiness.industryStentENDOVASCULAR REPAIRmedicine.diseaseAneurysmBlood Vessel ProsthesisSurgeryAbdominal aortic aneurysmSurgerybusinessTomography Spiral ComputedAortic Aneurysm AbdominalAbdominal surgeryEuropean Journal of Vascular and Endovascular Surgery
researchProduct

Clinical course and symptomatic prediagnostic period of patients with Wegener's granulomatosis and microscopic polyangiitis.

1998

The clinical course of 15 patients with Wegener's granulomatosis (WG) and eight patients with microscopic polyangiitis (MPA) from one nephrological clinical center is presented for the period from 1984 to 1993, when testing for antineutrophil cytoplasmic antibodies (ANCA) was gradually introduced into routine clinical practice. We found a high degree of prolonged time periods with symptoms attributable to WG or MPA until the specific diagnosis was made. Nine patients with WG and one patient with MPA had symptomatic prediagnostic periods of more than three years, which extended in one case up to twenty years. In these prediagnostic periods, often even severe flares of vasculitic activity res…

MaleVasculitisPediatricsmedicine.medical_specialtySystemic diseaseTime Factorsmedicine.medical_treatmentRemission SpontaneousSpontaneous remissionCritical Care and Intensive Care MedicineAntibodies Antineutrophil CytoplasmicRenal DialysismedicineRapidly progressive glomerulonephritisHumansCyclophosphamideDialysisAnti-neutrophil cytoplasmic antibodyRetrospective StudiesImmunosuppression Therapybusiness.industryGranulomatosis with PolyangiitisGeneral MedicineMiddle Agedmedicine.diseaseSurgeryNephrologyFemaleMicroscopic polyangiitisComplicationVasculitisbusinessImmunosuppressive AgentsRenal failure
researchProduct

Dialysis vintage time has the strongest correlation to psychosocial pattern of oral health-related quality of life – a multicentre cross-sectional st…

2018

Background Aim of this cross-sectional, multicentre study was to investigate associations of dialysis vintage time in haemodialysis (CKD5D) patients with oral health-related quality of life (OHRQoL) and dental and periodontal treatment need. Material and Methods CKD5D patients were divided into subgroups according to dialysis vintage time in different dialysis centres in Germany. OHRQoL was assessed with oral health impact profile (OHIP-G14). Dental treatment need was classified as presence of carious lesions. Periodontal treatment need was defined as periodontal screening index score (PSI) 3-4. Results In total, 190 participants were divided into the subgroups according to the time on CKD5…

MaleVintagemedicine.medical_specialtyTime FactorsCross-sectional studymedicine.medical_treatment030232 urology & nephrologyOral HealthOral healthCorrelation03 medical and health sciences0302 clinical medicineQuality of lifeRenal DialysisInternal medicinemedicineHumansRenal Insufficiency ChronicCorrelation of DataGeneral DentistryDialysisAgedbusiness.industryResearch030206 dentistryMiddle AgedMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]humanitiesstomatognathic diseasesCross-Sectional StudiesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASCohortQuality of LifeFemaleSurgerybusinessPsychosocialMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study

2018

Background Compared with conventional haemodialysis (HD), online haemodiafiltration (OL-HDF) achieves a more efficient removal of uraemic toxins and reduces inflammation, which could favourably affect nutritional status. We evaluate the effect of OL-HDF on body composition and nutritional status in prevalent high-flux HD (HF-HD) patients. Methods In all, 33 adults with chronic kidney disease (CKD) Stage 5 undergoing maintenance HF-HD were assigned to post-dilution OL-HDF (n = 17) or to remain on HF-HD (n = 16, control group) for 12 months. The primary outcome was the change in lean tissue mass (LTM), intracellular water (ICW) and body cell mass (BCM) assessed by multifrequency bioimpedance …

Maledialysis patientsNon-Randomized Controlled Trials as Topicmuscleconvective therapies[SDV]Life Sciences [q-bio]medicine.medical_treatment030232 urology & nephrology030204 cardiovascular system & hematologyBody compositionGastroenterology0302 clinical medicineEstadística e Investigación Operativanocturnal homeMedicineProspective StudiesProspective cohort studyWasting2. Zero hungerhemodialysishigh-flux hemodialysisMiddle AgedUrology & Nephrology3. Good healthhaemodialysisHaemodialysisnutritionHaemodiafiltrationNephrologyall-cause mortalityFemaleHemodialysischronic kidney-diseasemedicine.symptomProtein-energy wastingspectroscopymedicine.medical_specialtyNutritional StatusHemodiafiltrationhaemodiafiltrationsurvivalCachexia03 medical and health sciencesRenal DialysisStatistical significanceInternal medicinebioimpedanceHumansDialysisNutritionInflammationbody compositionTransplantationbusiness.industrymedicine.diseaseConfidence intervalCase-Control StudiesKidney Failure Chronicmassprotein-energy wastingbusinessconventional hemodialysisHospitals High-VolumeKidney diseaseNephrology Dialysis Transplantation
researchProduct

Impact of COVID-19 Pandemic in Children with CKD or Immunosuppression

2021

Infections are a major concern in children on KRT and with CKD. Risk factors include immunosuppression, multiple contacts in dialysis units, and hospital visits ([1][1]). Italy was one of the countries most affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak ([2][2

Malemedicine.medical_specialty2019-20 coronavirus outbreakAdolescentCoronavirus disease 2019 (COVID-19)EpidemiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.medical_treatmentglomerular disease030232 urology & nephrologyComorbidity030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineRisk Assessmentchronic kidney disease; COVID-19; immunosuppression; kidney transplantation; glomerular disease; childrenImmunocompromised Host03 medical and health sciences0302 clinical medicinechildrenRenal DialysisRisk FactorsInternal medicinePandemicHumansMedicineRenal Insufficiency ChronicChildCOVID-19; children; chronic kidney disease; glomerular disease; immunosuppression; kidney transplantation; Adolescent; Age Factors; Child; Child Preschool; Comorbidity; Female; Humans; Infant; Italy; Kidney Transplantation; Male; Renal Dialysis; Renal Insufficiency Chronic; Risk Assessment; Risk Factors; COVID-19; Immunocompromised HostKidney transplantationTransplantationimmunosuppressionbusiness.industryAge FactorsCOVID-19InfantOutbreakImmunosuppressionmedicine.diseaseKidney TransplantationResearch LettersItalyNephrologyChild PreschoolDialysis unitFemalebusinesschronic kidney diseaseClinical Journal of the American Society of Nephrology
researchProduct

A new machine learning approach for predicting the response to anemia treatment in a large cohort of End Stage Renal Disease patients undergoing dial…

2015

Chronic Kidney Disease (CKD) anemia is one of the main common comorbidities in patients undergoing End Stage Renal Disease (ESRD). Iron supplement and especially Erythropoiesis Stimulating Agents (ESA) have become the treatment of choice for that anemia. However, it is very complicated to find an adequate treatment for every patient in each particular situation since dosage guidelines are based on average behaviors, and thus, they do not take into account the particular response to those drugs by different patients, although that response may vary enormously from one patient to another and even for the same patient in different stages of the anemia. This work proposes an advance with respec…

Malemedicine.medical_specialtyAnemiamedicine.medical_treatmentPopulationHealth InformaticsIron supplementMachine learningcomputer.software_genreModels BiologicalEnd stage renal diseaseCohort StudiesMachine LearningRenal DialysismedicineHumansIntensive care medicineeducationDialysiseducation.field_of_studybusiness.industryAnemiamedicine.diseaseAnemia managementComputer Science ApplicationsLarge cohortKidney Failure ChronicFemaleArtificial intelligencebusinesscomputerKidney diseaseComputers in Biology and Medicine
researchProduct

Tunnelled Haemodialysis Catheter Removal: An Underappreciated Problem, Not Always Simple and Safe

2020

Background: Optimal care of patients treated with a central tunneled catheter (CTC) as vascular access for hemodialysis requires a number of procedures. One of them is CTC removal, usually carried out using mostly the cut-down method (CDM) and the traction method (TM). The procedure seems to be simple and safe

Malemedicine.medical_specialtyCatheterization Central Venouscentral tunneled cathetersHealth Toxicology and Mutagenesismedicine.medical_treatment030232 urology & nephrologyVascular accesslcsh:Medicine030204 cardiovascular system & hematologyTraction MethodArticle03 medical and health sciences0302 clinical medicineCatheters IndwellingRenal DialysismedicineHumansIn patientTunneled catheterDevice Removalchronic kidneys diseaseAgedRetrospective StudiesAged 80 and overhemodialysisbusiness.industrylcsh:RPublic Health Environmental and Occupational Healthvascular accessMiddle AgedSurgeryTreatment OutcomeHaemodialysis catheterFemaleHemodialysisbusinessInternational Journal of Environmental Research and Public Health
researchProduct